Maven Securities’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-2,250
Closed -$655K 103
2018
Q1
$655K Buy
+2,250
New +$570K 0.35% 48

Other funds holding ABMD

Maven Securities's ABMD Position: Q2 2018 in Review

Maven Securities sold out of Abiomed Inc (ABMD) in Q2 2018, closing a stake of 2,250 shares — an estimated $655K sold.

Maven Securities first reported a position in ABMD in Q1 2018 and held it in 1 quarter. The position peaked at $655K in Q1 2018. 527 funds tracked by Wall St. Rank hold ABMD as of Q2 2018.

  • Maven Securities reported no remaining Abiomed Inc position as of Q2 2018 after selling out during the quarter.
  • Maven Securities sold 2,250 Abiomed Inc shares in Q2 2018, an estimated $655K.
  • Maven Securities first reported a position in Abiomed Inc in Q1 2018 and held it in 1 quarter.
  • Maven Securities's Abiomed Inc position peaked at $655K in Q1 2018.
  • 527 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2018.

Based on Maven Securities's 13F filing for Q2 2018, filed 13 Aug 2018.